Equities

Charles River Laboratories International Inc

Charles River Laboratories International Inc

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (USD)141.86
  • Today's Change0.186 / 0.13%
  • Shares traded150.88k
  • 1 Year change32.49%
  • Beta1.0340
Data delayed at least 15 minutes, as of Feb 21 2019 19:23 GMT.
More ▼

Key statistics

Charles River Laboratories International Inc (CRL:NYQ) set a new 52-week high during today's trading session when it reached 142.70. Over this period, the share price is up 34.30%.
52-week range
Today
101.58Apr 06 2018142.70Feb 21 2019
Markit short selling activity
Low
Med
High
Open141.32
High142.70
Low140.59
Bid141.81
Offer141.94
Previous close141.67
Average volume464.82k
Shares outstanding48.23m
Free float47.43m
P/E (TTM)31.63
Market cap6.83bn USD
EPS (TTM)4.48
USD
Data delayed at least 15 minutes, as of Feb 21 2019 19:23 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.